$Bilateral patellar fractures and increased cortical bone thickness associated with long-term oral alendronate treatment in a cat$

Bilateral patellar fractures and increased cortical bone thickness associated with long-term oral alendronate treatment in a cat

Bibliographic Details
Format:	Article
Language:	English
Published:	SAGE Publishing 2018-08-01
Series:	Journal of Feline Medicine and Surgery Open Reports
Online Access:	https://doi.org/10.1177/2055116918798187

Similar Items

Bilateral patellar fractures and increased cortical bone thickness associated with long-term oral alendronate treatment in a cat
by: Nicola Council, et al.
Published: (2017-08-01)

Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
by: Ravindra Gudena, et al.
Published: (2011-01-01)

Bilateral traumatic patellar fracture: a case report and
by: Vinay Gupta, et al.
Published: (2012-06-01)

Long-Term Alendronate Use Not without Consequences?
by: M. P. Somford, et al.
Published: (2009-01-01)

Patellar Thickness and its Implication on Patellar Resurfacing
by: S Vijayamohan, et al.
Published: (2020-10-01)

Patellar Sleeve Fracture
by: Scott Sullivan, et al.
Published: (2014-11-01)

Study of DXA-derived cortical bone thickness in assessing hip fracture risk
by: Long, Yujia
Published: (2014)

Effects of long-term alendronate treatment on bone mineralisation, resorption parameters and biomechanics of single human vertebral trabeculae
by: M Krause, et al.
Published: (2014-09-01)

Modeling the Long Term Effects of Alendronate on Bone Mass Preservation of the Femur with Articular Surface and Total Hip Replacements
by: Hryce, Trevor J
Published: (2010)

Simultaneous bilateral patellar tendon rupture
by: Diogo Lino Moura, et al.

Atypical femoral fracture after long-term alendronate treatment: Report of a case evidenced with magnetic resonance imaging
by: Chih-Ming Kao, et al.
Published: (2012-10-01)

Analysis of cortical bone quality in long-term bisphosphonate users with atypical femur fracture (AFF)
by: Delphine Farlay, et al.
Published: (2020-10-01)

Measuring the Nanoindentation Properties of Alendronate-Time Treated Canine Cortical
by: Ashaolu, Folorunso
Published: (2011)

Long-term treatment with alendronate increases the surgical difficulty during simple exodontias – an in vivo observation in Holtzman rats
by: Conte-Neto Nicolau, et al.
Published: (2012-07-01)

WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk.
by: Hou-Feng Zheng, et al.
Published: (2012-07-01)

Patellar Bone Tumor
by: Abolhasan Borjian, et al.
Published: (2008-06-01)

Effects of Short Term and Long Term Usage of Patellar Kinesio Taping on Patellar Position in Women with Patellofemoral Pain Syndrome
by: Mahboobeh Banejad, et al.
Published: (2016-06-01)

Simultaneous bilateral patellar tendon rupture without
by: LU Hua-ding, et al.
Published: (2012-04-01)

Impact of ACL Injury on Patellar Cartilage Thickness
by: Leveillee, Ethan
Published: (2016)

Study of DXA-derived lateral–medial cortical bone thickness in assessing hip fracture risk
by: Yujia Long, et al.
Published: (2015-06-01)

Commentary: Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone
by: Xiang-Dong Wu, et al.
Published: (2017-11-01)

The Impact of Alendronate on Bone Mineral Density of Osteoporotic Patients
by: Hamidreza Aghaei-Meybodi, et al.
Published: (2013-12-01)

Alendronate in patients with calcium nephrolithiasis and loss of bone mass
by: Arrabal-Polo Miguel, et al.
Published: (2012-08-01)

The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
by: S. Akı, et al.
Published: (2002-03-01)

Short term sodium alendronate administration improves the peri-implant bone quality in osteoporotic animals
by: Danila de OLIVEIRA, et al.

Bilateral Atraumatic Patellar Ligament Rupture- Case Report
by: Raul Hernandez Juliato, et al.

Fracture of an uncemented tantalum patellar component
by: Nathan L. Grimm, MD, et al.
Published: (2016-06-01)

Supplement With Calcium or Alendronate Suppresses Osteopenia Due to Long Term Rabeprazole Treatment in Female Mice: Influence on Bone TRAP and Osteopontin Levels
by: Aly A.M. Shaalan, et al.
Published: (2020-05-01)

The Effect of Damage on the Long-Term Viability of Cortical Bone Allografts
by: Brinkman, Jennifer G.
Published: (2010)

Atypical stress femoral shaft fracture secondary to alendronate therapy
by: Javier Ardebol, et al.
Published: (2020-01-01)

Alendronate-Associated Ulnar and Tibial Fractures: A Case Report
by: Zhi Hao Tang, et al.
Published: (2011-12-01)

Alendronate-Associated Femoral Insufficiency Fractures and Femoral Stress Reactions
by: Kemble Wang, et al.
Published: (2011-04-01)

Arthroscopic patellar release for treatment of chronic symptomatic patellar tendinopathy: long-term outcome and influential factors in an athletic population
by: Gernot Lang, et al.
Published: (2017-11-01)

A cadaveric study of the location and morphology of the central patellar ridge for bone-patellar tendon-bone graft
by: Thanathep Tanpowpong, et al.
Published: (2021-01-01)

Impairment of cold injury-induced muscle regeneration in mice receiving a combination of bone fracture and alendronate treatment.
by: Shigeo Kawada, et al.
Published: (2017-01-01)

Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture
by: Iwamoto J, et al.
Published: (2011-06-01)

The Patellar Resurfacing in Total Knee Prosthesis: Indications for Bone Stock and Patellar Morphology
by: Luigi Molfetta, et al.
Published: (2021-02-01)

Clinical Results and MRI Evaluation of Patellar Osteochondral Fracture Fixation following Patellar Dislocation
by: Krzysztof Małecki, et al.
Published: (2019-01-01)

Increased cortical porosity and reduced cortical thickness of the proximal femur are associated with nonvertebral fracture independent of Fracture Risk Assessment Tool and Garvan estimates in postmenopausal women.
by: Rita Kral, et al.
Published: (2017-01-01)

Oral squamous cancer cell-bone interactions and resistance to alendronate (Fosamax) drug therapy in 3D-live bone-microenvironment
by: Hwang, Melody
Published: (2018)